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PURPOSE. Throughout adulthood, Bruch membrane (BrM) accu-
mulates esterified cholesterol (EC) associated with abundant
60- to 80-nm-diameter lipoprotein-like particles (LLP), putative
apolipoprotein B (apoB) lipoproteins secreted by the retinal
pigment epithelium (RPE). In the present study, neutral lipid,
phospholipids, and retinoid components of human BrM-LLP
were assayed.
METHODS. Particles isolated from paired choroids of human
donors were subjected to comprehensive lipid profiling (pre-
parative liquid chromatography [LC] gas chromatography
[GC]), thin-layer chromatography (TLC), high-performance liq-
uid chromatography (HPLC), Western blot analysis, and nega-
tive stain electron microscopy. Results were compared to
plasma lipoproteins isolated from normolipemic volunteers
and to conditioned medium from RPE-J cells supplemented
with palmitate to induce particle synthesis and secretion.
RESULTS. EC was the largest component (32.4  7.9 mol%) of
BrM-LLP lipids. EC was 11.3-fold more abundant than triglyc-
eride (TG), unlike large apoB lipoproteins in plasma. Of the
fatty acids (FA) esterified to cholesterol, linoleate (18:2n6) was
the most abundant (41.7  4.7 mol%). Retinyl ester (RE) was
detectable at picomolar levels in BrM-LLP. Notably scarce in
any BrM-LLP lipid class was the photoreceptor-abundant FA
docosahexaenoate (DHA, 22:6n3). RPE-J cells synthesized apoB
and numerous EC-rich spherical particles.
CONCLUSIONS. BrM-LLP composition resembles plasma LDL
more than it does photoreceptors. An EC-rich core is possible
for newly synthesized lipoproteins as well as those processed
in plasma. Abundant EC could contribute to a transport barrier
in aging and lesion formation in age-related maculopathy
(ARM). Analysis of BrM-LLP composition has revealed new
aspects of retinal cholesterol and retinoid homeostasis. (Invest
Ophthalmol Vis Sci. 2009;50:870–877) DOI:10.1167/iovs.08-
2376
Age-related maculopathy (ARM) is the leading cause of new,untreatable vision loss in the elderly of industrialized na-
tions.1 Its main clinical and histopathologic lesions affect the
retinal pigment epithelium (RPE; support cells for photorecep-
tors), Bruch membrane (BrM; a thin intima-like extracellular
matrix), and the choriocapillaris vessels, ultimately impacting
vision by the photoreceptors.2 Early ARM is characterized by
drusen (focal extracellular debris), basal linear deposit (BlinD;
a diffusely distributed drusenoid material), and altered RPE
morphology and pigmentation. This disease stage has limited
treatment options, including antioxidant nutritional supple-
ments, and, in its later stages, loss of eyesight is possible.
Although some gene sequence variants increase ARM risk,3 the
largest risk factor for early ARM remains advanced age. It is
therefore important to understand how age-related changes in
the affected tissues impel some individuals toward severe dis-
ease.
Lipoproteins are naturally occurring nanoparticles com-
posed of lipid and protein held together by noncovalent forces.
Each particle is a microemulsion consisting of a surface of
phospholipids (PLs), unesterified cholesterol (UC), and apoli-
poproteins and a core of neutral lipids, principally esterified
cholesterol (EC) and triglyceride (TG). Lipoprotein classes dif-
fer in relative amount of lipids, protein/lipid ratio, and apoli-
poprotein species present, resulting in differences in size,
density, and electrophoretic mobility. Lipoprotein classes con-
taining apoB are chylomicrons (CM; from intestine), very-low-
density lipoproteins (VLDL; from liver), and LDL (metabolite of
VLDL). ApoB lipoproteins must be properly lipidated by their
source cells in order for particle maturation and secretion to
proceed. Core lipid composition reflects the availability of
input FA and the substrate preferences of catalytic enzymes in
upstream pathways.4
From late adolescence through senescence, BrM in normal
human eyes markedly accumulates histochemically detectable
EC associated with abundant 60- to 80-nm-diameter solid li-
poprotein–like particles (LLP).5–8 Further, drusen contain EC,
UC, and immunoreactivity for apos A-I, B, C-I, C-II, and E.9 This
deposition is not necessarily attributable to the systemic aging
phenomenon by which EC from LDL accumulates in connec-
tive tissues, including arterial intima and cornea.10 Rather,
recent evidence implicates EC as part of an apoB lipoprotein
constitutively produced within the eye by the RPE and se-
creted into BrM, where it participates in ARM progression.
Native human RPE expresses apolipoprotein mRNA tran-
scripts, the proteins of apos B-100 and E, and notably, micro-
somal triglyceride transfer protein (MTP), required for apoB
secretion and the product of the abetalipoproteinemia
gene.11,12 Isolated BrM-LLP segregate into the appropriate
band of a density gradient but differ from plasma lipoproteins
in cholesterol profile.13 Cultured RPE secretes apoE, primarily
into a high-density fraction.14
Size and lipid composition are strongly related for apoB
lipoproteins, in that particles 25 nm diameter (CM and VLDL)
have TG-rich cores and smaller particles (including LDL) have
EC-rich cores.15 BrM-LLP, as large as VLDL or small CM, are
expected to be TG-rich. Indeed, an early assay of BrM/choroid
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indicated 1.77-fold more moles TG than EC.16 However, other
studies in which polarizing microscopy in tissue sections6 and
enzymatic assay in isolated particles13 were used indicate that
EC predominates over TG by at least threefold. To facilitate
insight into the biological function of BrM-LLP and improve
understanding of the lipids available to form the characteristic
ARM extracellular lesions, we used comprehensive profiling of
neutral lipid, PL, and retinoid components of BrM-LLP isolated
from human donor eyes, comparing these results to plasma
apoB lipoproteins and the secreta of an RPE cell line.
METHODS
Preparation of Human Donor Eyes and Isolation
of Particles
Human tissue use conformed to the Declaration of Helsinki and insti-
tutional review at the University of Alabama, Birmingham (UAB). BrM-
LLP were isolated from BrM/choroids (Fig. 1A) of 11 paired donor eyes
(Table 1), as described.13 From BrM/choroids of four donors, total
lipids were extracted without prior lipoprotein isolation (Table 1).
Changes consistent with ARM were noted in 4 of 15 donors. We
processed donor eyes in the order received, and we did not analyze the
ARM eyes separately, because there were too few to permit valid
conclusions. Peripheral drusen were present in all older eyes. Flattened
choroids (Fig. 1A) were scanned for area determination (described
later). Supernatants generated from three rounds of tissue homogeni-
zation, centrifugation, and resuspension in isolation buffer13 contain-
ing 1 M NaCl17 were pooled. The pellet (BrM remainder) was saved at
80°C for separate analysis. Density was adjusted to 1.24 g/mL (by
weight) by adding solid KBr, overlaid with 1 mL of 1.21 g/mL KBr, and
centrifuged (49,000 rpm, 36 hours, 10°C, SW41Ti rotor, L80 ultracen-
trifuge, Beckman, Fullerton, CA). One half milliliter of each superna-
tant (d 1.21 g/mL, lipoprotein-containing, called the top fraction) and
infranatant (d  1.21 g/mL, lipoprotein-sparse, called the bottom
fraction) were withdrawn (Fig. 1B) for various assays.
Preparation of Human Plasma Lipoproteins
Plasma from four normolipemic volunteers, obtained at 4 postpran-




Lipids were extracted from BrM-LLP, BrM remainders, medium, and
cells by using chloroform-methanol (2:1 vol/vol).18 Aliquots of organic
phase were evaporated under nitrogen, resolubilized in chloroform,
FIGURE 1. Preparation of BrM-LLP. (A) Flatmounted choroid of human
eye. Pigmented stroma is apparent between the clear lumens of large
vessels. BrM is the top 2- to 4-m-thick layer of the choroid. (B) Tube
contains a cloudy top layer (d  1.21 g/mL) containing LLP (arrow)
below a bright white meniscus. (C) Negative-stain electron micrograph
of the cloudy layer shows scattered solid, electron-lucent particles
(arrow). (D) Frequency histogram of particle diameters pooled from
three donors. (E) Western blot shows apoE in HDL (H, positive con-
trol) and in the top (T) and bottom (B) fractions of a KBr density
gradient from donors 8-01 and 7-26. Left: molecular weight standards.
Arrowhead: ApoE, at 35 kDa. Scale bar: (A) 5 mm; (C) 500 nm.







Tissue§ UseLeft Eye Right Eye
6–08 86 M Cauc 5:35 n.r. ARM BrM/Ch LC-GC
7–13 74 M Cauc 6:10 Normal Normal BrM/Ch LC-GC
7–14 78 M Cauc 6:34 Normal Normal BrM/Ch LC-GC
7–16 72 F Cauc 8:10 Normal Normal LLP, R LC-GC, HPLC
7–17 37 M A-A 7:48 Normal Normal BrM/Ch LC-GC
7–18 90 M Cauc 8:13 Ex-ARM Early ARM LLP, R LC-GC, HPLC, TLC
7–21 85 F Cauc 21:52 Normal Normal LLP, R LC-GC, HPLC, TLC
7–22 59 M A-A 9:27 Macular hole n.r. LLP, R LC-GC, HPLC, TLC
7–23 51 M Cauc 2:55 Normal Normal LLP, R LC-GC, HPLC, TLC
7–24 87 F Cauc 9:36 Normal Normal LLP, R LC-GC, HPLC, TLC
7–25 86 M Cauc 12:14 Early ARM Early ARM LLP, R LC-GC, HPLC, TLC
7–26 82 F Cauc 7:49 Normal Normal LLP TLC, WB
7–27 79 M Cauc 13:04 Normal Normal LLP EM
7–29 82 M Cauc 6:22 Early ARM Early ARM LLP EM, TLC
8–01 52 F Cauc 12:20 Normal Normal LLP EM, WB
* Cauc, Caucasian; A-A, African-American.
† Death to processing time.
‡ Assessed by an ophthalmologist; early ARM, drusen and pigmentary changes; Ex-ARM, late exudative ARM; n.r., not recorded; all donors were
nondiabetic.
§ BrM/Ch, BrM and choroid tissue, shown in Fig. 1A; LLP, particles in d  1.21 g/mL fraction; R, remainder (BrM/Ch after LLP removal).
 LC-GC, lipid profiling by liquid chromatography and gas chromatography; HPLC, high-pressure liquid chromatography; TLC, thin layer
chromatography; WB, western blot; EM; negative stain electron microscopy.
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and applied to TLC plates (LHPKD silica gel 60A, Whatman, Florham
Park, NJ) as described.12 For separation of EC, TG, UC, FA, PE, and PC,
plates were developed in petroleum ether:diethyl ether:acetic acid
(84:15:1). For greater separation of PL and sphingomyelin (SPM), plates
were developed in chloroform: methanol: ammonium hydroxide (65:
25:4). Plates were sprayed with 3% copper acetate in 8% phosphoric
acid solution and heated to reveal bands. Standards were chloroform-
solubilized 1,2-dioleoyl-sn-glycero-3-phosphocholine, oleate, triolein,
cholesteryl oleate, SPM (esterified to mostly palmitate, 16:0), and UC
(SPM from Avanti Polar Lipids, Alabaster AL; others from Sigma-Aldrich,
St. Louis, MO). For semiquantitative assessment, plates were scanned,
bands were defined within contrast-inverted images, and band inten-
sities were measured (IPLab; BioVision Technologies, Exton, PA).
Comprehensive Lipid Profiling
BrM-LLP, plasma lipoproteins, and BrM/choroids were characterized
by Lipomics (West Sacramento, CA) using preparative liquid chroma-
tography (LC), gas chromatography (GC), and flame ionization detec-
tion. Lipids were extracted18 in the presence of authentic internal
standards. Individual lipid classes within each extract were separated
by LC (model 1100 series; Agilent Technologies, Palo Alto, CA). Each
lipid class was transesterified in 1% sulfuric acid in methanol in a sealed
vial under nitrogen at 100°C for 45 minutes. Resulting FA methyl esters
were extracted with hexane containing 0.05% butylated hydroxytolu-
ene and prepared for GC by sealing the hexane extracts under nitro-
gen. FA methyl esters were separated and quantified by capillary GC
(model 6890; Agilent Technologies) equipped with a 30-m capillary
column (DB-88MS; Agilent Technologies) and a flame-ionization detec-
tor.
HPLC for Retinoids
Two 50-L aliquots were taken of samples of BrM-LLP and plasma
lipoproteins and handled under safelight conditions. The first, assayed
for unesterified retinol, was mixed with 0.6 mL water and 1.5 mL
ethanol and then extracted twice with a double volume of hexane. The
second aliquot, assayed for unesterified retinol plus RE, was treated
with 1.5 mL 5% potassium hydroxide in ethanol for 15 minutes at 65°C
to permit RE hydrolysis and extracted as just described. The difference
between unesterified retinol and total retinol accounted for the retinol
released by hydrolysis from RE. Extracts were dried under nitrogen and
resolubilized in 200 L of HPLC mobile phase. Reversed-phase sepa-
ration was performed using a separation module (model 2695; Waters,
Milford, MA) with a photograph diode array detector (model 2996;
Waters) and a silica-based column (Supelcosil Suplex; pKB100 column;
250  4.6 mm, 5 M; Sigma-Aldrich) equipped with a C18 guard
column (Symmetry; Waters).The isocratic mobile phase consisted of
79% acetonitrile, 16% 0.25 M ammonium acetate, 3% glacial acetic acid,
and 2% methanol. The flow rate was 0.7 mL/min. Chromatograms were
extracted at 325 nm. Retinol peaks were identified by matching spectra
and elution times to those of retinol standards. Under-the-curve areas of
retinol peaks were converted to molar content using calibration coef-
ficients obtained by separating retinol standards of known concentra-
tions under the same conditions. Plasma lipoprotein RE contents (Sup-
plementary Table S1, column 12, http://www.iovs.org/cgi/content/
full/50/2/870/DC1) were comparable to values reported for post-
prandial normolipemic subjects19 (i.e., high in CM, moderate in VLDL,
and low to trace in LDL).
Cell Culture, Secretion, and Immunoprecipitation
RPE-J cells (from American Type Culture Collection, Manassas, VA)
were used for secretion after two passages. The cells were cultured in
T-75 flasks at 33°C and 5% CO2 for 6 days in DMEM and 4% fetal calf
serum. Although the long-chain FA oleate is typically used to elicit
apoB secretion from hepatoma cells,20 preliminary experiments indi-
cated that RPE-J responded better to palmitate. Serum-free DMEM
containing 0.2 M palmitate bound to 1.5% FA free-BSA was warmed
to 33°C and added into flasks. To detect newly synthesized apoB, 10
mL serum- and methionine-free DMEM containing 100 L [35S]-methi-
onine (10.5 Ci/L) were also added. After 4 hours, medium was
replaced with serum-free DMEM and incubated for another 4 hours.
The medium was centrifuged at 5000 rpm for 5 minutes to remove
cellular debris, and the supernatant was subjected to density gradient
ultracentrifugation before TLC, electron microscopy,13 or immunopre-
cipitation, as follows. The cells were washed with cold PBS, and
protein was extracted. [35S]-methionine-labeled cell extract and either
whole or fractionated conditioned medium was immunoprecipitated
with polyclonal rabbit anti-rat apoB-100 (5 mg/mL; gift of Janet Sparks,
University of Rochester, NY) bound to protein-G Sepharose, eluted,
resolved with a 5% polyacrylamide gel containing SDS, enhanced by
agitation in fluorographic reagent (Amplify; GE Healthcare, Piscataway
NJ), and exposed to film. The gel, which also contained LDL and
molecular weight markers, was stained with Coomassie blue and su-
perimposed on the film, to permit band verification.
Yield of Particles Isolated from BrM/Choroid:
Determination of Nanomoles per Eye
EC is localized almost exclusively to BrM (Rudolf M, et al. IOVS
2007;48:ARVO E-Abstract 2184). EC was therefore more suitable for
yield calculations than either protein or other lipids such as UC that are
present not only in BrM but are also abundant throughout the choroid.
We determined EC content in BrM-LLP and BrM remainders of each
donor eye pair using an enzymatic assay.13 Yield, calculated for each
donor as (nmol/mL EC in BrM-LLP)/(nmol/mL EC in BrM-LLP 
nmol/mL EC in BrM remainder), varied from 32% to 73% (median,
60%), with no obvious relation to age or maculopathy status. This value
was used in calculating nanomoles per eye for each lipid class except
SPM, which was independently assayed by TLC and quantified. SPM
yield ranged from 49% to 66% (median, 53%), comparable to yields for
EC and for lipoprotein particles similarly released from atherosclerotic
intima.17
Determination of Nanomoles per
Square Millimeter
Total yield-corrected BrM-LLP-derived lipid was expressed per square
millimeter of BrM/choroid, so that we could compare our results
directly with previous studies.16 We determined the area of flattened
BrM/choroids using digital planimetry (IPLab; BioVision Technologies).
This area was 843  130 mm2 for individual eyes. Lipid quantities were
converted to micrograms per square millimeters using the formula
weight of a representative compound for each lipid class (e.g., cho-
lesteryl oleate for EC, triolein for TG).
Additional Methods
Methods for Western blot analysis, enzymatic cholesterol assay, and
negative stain electron microscopy were described previously.13
RESULTS
We preliminarily assayed BrM/choroid lipids with TLC, as done
in the early study, concluding that this tissue contained more
TG than EC,16 and we found much less TG than EC (not
shown). Then, by lipid profiling of this tissue, we confirmed
EC’s abundance (1394 nanomoles/g, wet weight, in a 37-year-
old donor and 4119 to 5542 nanomoles/g in 3 donors  74
years). EC mass exceeded that of TG by 4.6- to 13.9-fold among
individual donors. Such compositional analyses of BrM/choroid
unavoidably combine neutral lipids of BrM with membrane-
associated UC and PL within choroidal cells and plasma li-
poproteins retained in vessels. Therefore, we next isolated and
characterized BrM-LLP in seven donors. The top fractions of
BrM homogenates contained numerous spherical electron-lu-
cent particles (Fig. 1C),13 whereas the bottom fractions con-
tained amorphous, heterogeneous material not clearly identifi-
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able as particles (not shown). Particle diameters varied from
11.3 to 211.6 nm in a single-mode, with a positively skewed
distribution with a median of 66.6 nm (Fig. 1D), similar to
VLDL, and in good agreement with LLP diameters measured in
situ.21 We previously showed that this fraction contains apoA-I
and apoB.13 Here, we detected apoE, a ubiquitous druse com-
ponent,9,11,22 by Western blot analysis in both fractions of BrM
homogenates (Fig. 1E), indicating that in addition to high-
density forms, apoE may also be present on the large LLP.
The BrM-LLP lipid profile, corrected for yield, is summarized
in Table 2 (columns 1 to 10), and the plasma lipoprotein profile
is shown in Supplementary Table S1, http://www.iovs.org/cgi/
content/full/50/2/870/DC1. The BrM-LLP fraction contained
791.8  376.8 nanomoles total lipid per eye, and each square
millimeter of BrM contained 0.44  0.16 nanomoles of LLP-
derived lipids. Lipid classes, in order of descending abundance,
were EC, UC, PC, PE, FA, PS, TG, CL, DAG, and LyPC. EC
constituted 32.4%  7.9% of the total. EC mass, the most
variable lipid, varied sevenfold among donors (Table 2), with-
out obvious explanation, but conforming to histochemical de-
scriptions.7 BrM-LLP differed notably from plasma lipoproteins
in several ways (Table 3). The mean EC/TG ratio was 11.3 
6.7, compared to 0.11, 0.13, and 8.5 for CM, VLDL, and LDL,
respectively. Thus, BrM-LLP were not TG-rich like CM or VLDL,
and their EC/TG ratio was high, similar to LDL. BrM-LLP PL
were also distinct, with the PC/PE ratio much lower than that
for plasma lipoproteins (1.29  0.19 vs. 6.0 to 14.9; Table 3).
Because lipid profiling did not include SPM, which is more
closely associated with UC than other PL in plasma mem-
branes,23 we determined the SPM content independently (Ta-
ble 2, column 11). We found 79.5  11.1 nmol/eye SPM, and
the ratio of SPM to PC measured on the same TLC plates was
0.70  0.13, much higher than the 0.28 to 0.37 ratio in plasma
lipoproteins (Table 3). Finally, CL and PS were detected in
BrM-LLP but not in plasma lipoproteins (Table 2 versus Sup-
plementary Table S1, http://www.iovs.org/cgi/content/full/
50/2/870/DC1).
Of the plasma apoB lipoproteins, only the neutral lipid core
of (small-diameter) LDL is as enriched in EC relative to TG as
are BrM-LLP. LDL attains this status through the action of
lecithin cholesterol acyl transferase, which acts on PC and UC
in circulating HDL to form LyPC and EC products that are
subsequently transferred to LDL by cholesteryl ester transfer
protein. It is important to determine whether high EC content
was possible for newly synthesized lipoproteins as well as
those released from BrM, where they may have been subjected
to similar metabolic remodeling in the extracellular compart-
ment. We therefore examined the secretory output of RPE-J, a
heat-transformed, rat-derived RPE cell line24 that reportedly
secretes protein robustly in culture.25 First, we verified that
lipoprotein assembly and secretion was possible for these cells
by seeking evidence of apoB and MTP expression and of
particle formation (Fig. 2). Western blot analysis revealed the
MTP large subunit at the predicted 97-kDa locations in liver
and RPE-J (Fig. 2A). When the RPE-J cells were provided with
palmitate and [35S]-methionine, newly synthesized apoB-100,
and a low-molecular-weight band were secreted into the whole
medium (Fig. 2B) and its top fraction (Fig. 2C). This fraction
also contained numerous spherical particles with a mean di-
ameter of 56 nm (Figs. 2D, 2E). We then used TLC to determine
the lipid composition of RPE-J-conditioned medium and cells
(Fig. 2F). In the particle-containing the top fraction, the EC/TG
ratio was 5.6. The cells were similarly EC-rich. For BrM-LLP on
the same TLC plate (Fig. 2F), the EC/TG ratio was 8.9.
In lipoprotein-secreting cells, the pathways contributing to
the neutral lipid core reflect different input lipids from those
contributing to the PL-rich surface.26,27 To provide insight into
potential sources of BrM-LLP lipids, we examined the distribu-
tion of FA in neutral lipids and PL of BrM-LLP and plasma
lipoproteins (FA with mol% 1% in Fig. 3, all FA in Supple-
TABLE 2. Lipid Profile of BrM Particles (nmol/eye and mole%, corrected for yield)
1 2 3 4 5 6 7 8 9 10 11 12
EC DG FA TG CL LYPC PC PE PS UC SPM RE
ID
7–16 193.2 7.9 36.3 18.0 n.a. n.a. 116.2 90.5 n.a. 159.0 78.0 0.053
7–18 84.7 10.7 29.3 16.0 19.7 14.1 43.9 n.a. 20.5 51.8 n.a. n.d.
7–21 506.2 13.6 47.1 20.1 19.7 9.0 177.3 112.0 46.9 304.4 82.9 0.040
7–22 210.2 13.7 64.8 30.7 24.9 28.4 116.8 106.0 57.9 215.3 91.9 0.051
7–23 157.8 13.5 45.2 20.4 19.5 9.4 105.2 95.4 49.0 195.2 68.0 0.145
7–24 561.0 15.4 60.0 42.5 41.6 10.3 149.0 103.6 51.6 263.2 90.5 0.403
7–25 180.8 7.3 28.6 17.7 24.6 9.0 59.7 48.0 20.7 100.4 65.7 0.009
Median, nmol/eye 193.2 13.5 45.2 20.1 19.7 9.4 116.2 95.4 46.9 195.2 80.4 0.052
Mean, nmol/eye 270.6 11.7 44.5 23.6 21.4 11.4 109.7 79.4 35.2 184.2 79.5 0.117
SD, nmol/eye 184.8 3.1 14.2 9.6 12.2 8.6 46.6 40.9 21.5 88.5 11.1 0.147
Mean, mole%* 32.4 1.7 6.3 3.3 3.2 1.8 14.2 9.5 4.6 22.9 n.a. n.a.
SD, mole%* 7.9 0.9 2.1 1.2 2.2 1.7 2.4 4.9 2.5 3.5 n.a. n.a.
Assays used: columns 1–10, LC-GC; column 11, TLC for polar lipids; column 12, reversed phase HPLC. EC, esterified cholesterol; DG,
diglyceride; FA, non-esterified fatty acid; TG, triglyceride; CL, cardiolipin; LYPC, lysophosphatidylcholine; PC, phosphatidylcholine; PE, phosphati-
dylethanolamine; PS, phosphatidylserine; UC, unesterified cholesterol; SPM, sphingomyelin; RE, retinyl ester; n.a., not available; n.d., not detected.
* Calculated relative to the sum of columns 1–10 for each eye (mean, 791.8  376.8 nmol/eye).
TABLE 3. BrM-LLP Compared to Plasma LP
EC/(ECUC) EC/TG PC/PE SPM/PC
BrM particles (SD) 0.58 (0.085) 11.32 (6.676) 1.29 (0.190) 0.70 (0.13)
CM 0.59 0.11 6.09 0.28*
VLDL 0.45 0.13 8.30 0.28*
LDL 0.69 8.52 14.90 0.37*
* Calculated from Ref. 15.
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mentary Table S2, http://www.iovs.org/cgi/content/full/50/2/
870/DC1; see Fig. 3 caption for FA nomenclature). Of FA
esterified to cholesterol (Fig. 3A), linoleate (18:2n6) was the
most abundant (41.7  4.7 mol%), followed by oleate (18:1n9;
18.4  1.3 mol%), palmitate (16:0; 15.6  1.6 mol%), arachid-
onate (20:4n6; 7.8  1.3 mol%), and myristate (14:0; 5.1  2.5
mol%). Relative to non-esterified FA and FA in TG (Figs. 3B,
3C), FA in EC included less 16:0, 18:0, and 18:1. Of the PC FA
(Fig. 3D), palmitate (16:0) was the most abundant (35.6  2.7
mol%), followed by oleate (18:1n9; 17.8  1.7 mol%), stearate
(18:0; 13.2  1.1 mol%), linoleate (18:2n6; 12.6  1.9 mol%),
and arachidonate (20:4n6; 9.7  0.79 mol%). PE and PS (Fig.
3E, 3F) differed from PC by having much less palmitate (9%–
12%) and more DHA (but still 2 mol%). Within each lipid
class, BrM-LLP FA were overall remarkably similar to plasma
lipoproteins, with the principal exception of lower linoleate
(18:2n6) among nonesterified FA, TG, PC, and PE. Notably
scarce in any BrM-LLP lipid class was the photoreceptor-abun-
dant FA DHA (0.5  0.1 mol% in EC, 1.0  0.4 mol% in PC).
We previously speculated that a presumptively TG-rich BrM-
LLP would be an excellent mechanism whereby the RPE could
dispose of FA generated from PL in membranes of ingested
photoreceptor outer segments (OS).12 The paucity of TG and
DHA in BrM-LLP prompted us to consider other hypotheses
about major functions of this particle. Because dietary CMs
transport the lipophilic vitamins A, E, and K, and mammalian
RPE has been recently postulated to efflux retinoids,28 we
asked whether BrM-LLP contain RE. Figures 4A and 4B show
that no free retinol was detectable in the top fraction, but after
hydrolysis, released retinol was readily detectable at widely
ranging picomolar levels (24–768 pmol/mL) in six of seven
tested donor eye pairs. Neither free nor released retinol was
detected in the bottom fraction (not shown). The median RE
content (yield-corrected) in BrM-LLP of individual eyes was 52
picomoles (Table 2, column 12).
DISCUSSION
The universal and sizeable age-related deposition of neutral
lipid in BrM is an enigmatic antecedent of cholesterol-contain-
ing drusen and BlinD in ARM eyes. Information from human
eyes presented herein will help constrain and inform emerging
mouse models, generated by manipulating apolipoprotein
pathways, that exhibit different degrees of BrM lipid deposi-
tion.29–33 Our principal findings, obtained with comprehen-
sive lipid assays, are that BrM-LLP are EC-rich, not TG-rich, as
predicted by their size. Secretion of apoB and comparably
cholesterol-rich particles can be elicited from an FA-supple-
mented RPE cell line in vitro, BrM-LLP FA composition resem-
bles plasma LDL more than it does photoreceptor OS, and
BrM-LLP contain RE. Obvious differences were not detected
between ARM and non-ARM eyes, but due to the choice of
lipids analyzed and the small sample, it is premature to con-
clude that LLP composition in ARM and normal eyes are iden-
tical. Herein, we relate our data to BrM-LLP source cells, core
composition, and input lipids, with implications for ARM
pathogenesis and for retinoid biology.
BrM-LLP reside in a tissue bounded on one side by plasma in
the choroid and on the other side by RPE, making determining
the predominant source a challenge. For example, LDL could
infiltrate from plasma into BrM, become modified, and fuse to
form larger particles, as it does in intima,34 although such
fusion is rarely observed in BrM.8 In the present study, we
showed that an RPE cell line has an apparently functional
mechanism for apoB biosynthesis, assembly, and secretion. We
chose for these experiments the rat-derived cell line RPE-J,
although cognizant that key facets of lipoprotein metabolism
differ in rats and humans. In brief, rats carry plasma cholesterol
principally in HDL rather than LDL, they lack the cholesterol
ester transfer protein, and they synthesize apoB-48 in hepato-
cytes as well as enterocytes.35,36 Nevertheless, we were able to
demonstrate that RPE-J extracts and medium contained a high-
molecular-weight band readily immunoprecipitable by an anti-
body with documented specificity for rat apoB.37 We also
detected a solitary lower molecular weight band at a location
consistent with apoB-48 (unlike human RPE11,12). Easily pro-
teolyzed apoB-100 is vulnerable to oxidative degradation in our
iron-containing culture medium, but had this process oc-
curred, we may have expected many low-weight bands instead
of just one. As no in situ evidence for LLP in the extracellular
matrix apical to RPE yet exists, basolateral secretion is the
currently most plausible mechanism to account for BrM-LLP.
We proceed under this assumption, but acknowledge that
many details of an RPE apoB pathway require further elucida-
tion and that a plasma contribution to BrM lipids is not ex-
cluded.
From our observations that EC is the dominant neutral lipid
in nonhomogenized BrM/choroid and that RPE-J cells produce
EC-rich large particles in culture, we infer that the high cho-
lesterol content of BrM-LLP is not attributable to transfer or
degradation of TG from originally TG-rich particles. The RPE
appears unique among apoB secretors in producing a particle
that is EC-rich by direct biosynthesis rather than by postsecre-
tion metabolic remodeling, although we cannot yet exclude a
role for secreted enzymes. What controls the EC/TG ratio in a
FIGURE 2. RPE-J cells synthesize and secrete apoB and EC-rich parti-
cles. (A) Western blot of MTP in RPE-J cells and rat liver. Human LDL
was used as a negative control, because its only protein is apoB. RPE-J
cellular protein (100 g), rat liver protein (10 g), and LDL (1 g,
sufficient for apoB detection in test blots) were loaded. MTP was found
at the predicted 97-kDa location (arrow). (B, C) Immunoprecipitation
of [35S]-methionine labeled, newly synthesized apoB in cells and me-
dium of palmitate-supplemented RPE-J cells. Arrow: apoB-100 (512
kDa) and a 250-kDa band, possibly apoB-48, in cells and whole medium
(B), and in the top fraction only of fractionated medium (C). (D, E) A
fraction containing RPE-J-secreted particles was examined by electron
microscopy after negative staining with phosphotungstic acid (D).
Frequency histogram of diameters (E, n  489) is from one experi-
ment. (F) RPE-J particles and BrM-LLP are both EC-rich. TLC plate
shows lanes for standards, top and bottom fractions of medium con-
ditioned by palmitate-supplemented RPE-J cells, RPE-J cells, top and
bottom fractions of BrM-LLP from donor 07-29, and BrM/choroid re-
mainder (R) with unreleased particles.
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lipoprotein core? The predictable apoB lipoprotein size and
composition relationship, wherein circulating particles be-
come EC-rich as they shrink from CM to remnants and from
VLDL to LDL, reflects in part conformations imposed by parti-
cle surface curvature for lipases and transferases. Less clear is
what governs EC/TG in nascent lipoproteins, typically studied
in culture to escape these plasma effects. Overexpression in
hepatoma cells of mRNA encoding cellular enzymes catalyzing
esterification of either glycerol or cholesterol to fatty acyl Co-A
(DGAT-1,-2 and ACAT-1,-2, respectively4) can modify neutral
lipid composition, suggesting that adequate stores of either EC
or TG can permit particle maturation.4 Indeed, overexpression
of ACAT-2, expressed by lipoprotein-secreting hepatocytes and
enterocytes, can convert cells from secreting strongly TG-rich
particles to secreting strongly EC-rich particles.38 RPE cell
lines, initially thought to express only the more widely distrib-
uted ACAT1,12 have been recently shown to express ACAT239
as well. The cell type–specific balance in activity between
these two esterification mechanisms remains to be determined
for RPE.
What is the ultimate source of lipids feeding into BrM-LLP?
It has long been expected that the daily ingestion of photore-
ceptor OS by RPE results in the export of material to BrM.40 We
postulated that a TG-rich apoB lipoprotein would be an excel-
lent mechanism for releasing FA derived from PL in OS mem-
branes. Current and previously published compositional data
from BrM, LLP, and OS together provide little evidence for this
initially attractive hypothesis. First, OS phagocytosis is not
essential for neutral lipid secretion, based on experiments
using FA supplementation of RPE cell lines.12 Second, BrM-LLP
are not TG-rich, shown in our study by LC-GC and TLC and
previously by two other techniques.6,13 Each method has
strengths and limitations, but all data agree that the original
report16 of high TG mass in BrM/choroid cannot be replicated.
(Our assays of BrM/choroid recovered 5.6- to 7.8-fold more
total lipid, depending on assumptions, than reported in Ref.
16) Third, BrM-LLP are highly enriched in both EC,7 absent
from photoreceptors, and UC, sparse in the discs that consti-
tute most OS membranes.41 Fourth, the FA composition of
neither the neutral lipids of the BrM-LLP core nor the PL of its
surface resemble OS, particularly regarding the top three com-
ponents: DHA, stearate, and palmitate.42 We offer several ex-
planations. First, OS lipids may be thoroughly catabolized by
RPE before resynthesis as particle components. Second, DHA is
efficiently recycled back to the retina,43 leaving little for ex-
port. Third, OS-derived lipids may be present in a form (e.g.,
oxidized44) not recognizable by our assays. Fourth, some lipid
classes may be selectively and extensively hydrolyzed in the
extracellular compartment after secretion (e.g., by choroid-
resident45 or RPE-secreted lipases), now a less likely option
based on our analysis of whole choroid and RPE-J conditioned
medium. Fifth, another input may dominate BrM-LLP, which
compositionally resemble LDL more than they do OS, despite
low linoleate levels. LDL taken up at RPE LDL receptors46,47
can modify lysosomal acid lipase activity and can partition
rapidly, within hours, into membranes of the neurosensory
retina.48 In this way, retina is unlike brain, which eschews
plasma lipoprotein cholesterol and relies almost exclusively on
endogenous synthesis.49 Further, the ARPE-19 cell line can take
FIGURE 3. FA in major lipid classes
of BrM-LLP and plasma lipoproteins.
Fourteen FA with mol% 1% for any li-
poprotein are shown (y-axis, mol%).
See Supplementary Table S2, http://
www.iovs.org/cgi/content/full/50/2/
870/DC1, for all FA from all lipid
classes. Along the x-axis, FA are di-
vided into families as follows: Sat,
saturated (no double bonds); Unsat,
unsaturated (one or more double
bonds, not at the n6 or n3 positions,
as produced by the action of 	9 de-
saturase and subsequent elongases);
6 and 3, omega-6, and omega-3
(double bonds in the n6 and n3 po-
sitions, respectively). FA notation:
CXX:Yn-Z, where XX is the length of
the carbon chain, Y is the number of
double bonds along the carbon
chain, and Z is the position of the
first double bond, counting from the
methyl carbon. The enzyme 	9 de-
saturase acts on the carbon-9 posi-
tion, counting from the carboxyl end
of the molecule rather than the
methyl carbon. Therefore, 	9 desatu-
rase metabolites named using the n
nomenclature, as shown in this fig-
ure and in Supplementary Table S2,
will not all have the first double bond
in the 9 position.
FIGURE 4. HPLC detection of RE. BrM-LLP from donor 07-21 were
extracted without alkaline hydrolysis to detect free retinol (A). An
equal aliquot of the same sample was hydrolyzed before extraction to
release retinol from esterified forms (B). Chromatograms were ex-
tracted at 325 nm. Arrow: position of retinol. The identity of the large
peak is unknown. The y-axis represents arbitrary units.
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up xanthophylls destined for macular pigment, normally trans-
ported in plasma on lipoproteins, via a basally expressed scav-
enger receptor.50 Rather than disposing of OS, then, perhaps
BrM-LLP dispose of the residual components of plasma lipopro-
teins after extracting specific nutrients.
The EC-enrichment of BrM-LLP has implications for ARM
pathogenesis with regard to transport properties and lesion
formation. In vivo BrM-LLP preferentially accumulate in the
middle and inner layers of BrM (closer to the RPE), occupying
one eighth of the tissue volume at those sites in eyes aged 60
years.8,21 In the Lipid Wall, located closest to the RPE in the
same horizontal plane as BlinD, tightly packed layers of BrM-
LLP fill more than one third of tissue volume.7 The barrier
hypothesis posits that this age-related accumulation of neutral
lipids blocks translocation of nutrients to the RPE and photo-
receptors as well as the outward flow of fluid and metabolites,
thereby causing deleterious cellular stress.5,51 EC is the most
hydrophobic lipid in mammalian physiology,52 indicating that
aged BrM, particularly in eyes with a Lipid Wall,7,53 should
indeed present a formidable barrier. Our data may facilitate the
construction of and informed experimentation with in vitro
model systems to study transport across natural and artificial
matrices, perhaps using readily available LDL as an acceptable
surrogate because of its high EC content.54 Further, survival of
healthy RPE transplanted to aged BrM55 may be improved by
EC-solubilizing treatments. With regard to lesion formation,
cholesterol crystals, the hallmark of a mature atherosclerotic
plaque, have never been described in BrM or drusen. A previ-
ous speculation56 that high TG levels16 could maintain EC
solubility and forestall crystal development is rendered unten-
able by the current data. Of relevance is our detecting UC-avid
SPM in higher concentrations (SPM/PC  0.7) than reported
for plasma lipoproteins (SPM/PC  0.3) but in lower concen-
trations than in insoluble plaque (SPM/PC  1.6).57 That BrM-
LLP contain abundant EC supports the interpretation that
BlinD/ drusen contain ultrastructurally visible pooled EC, like
that in atherosclerotic intima.56,58,59
Of particular interest is the finding that BrM-LLP contain RE,
with high between-individual variability (in mol%) perhaps due
to uncontrolled exposure to light postmortem. Vitamin A de-
rivatives are required for normal phototransduction, and reti-
nol is delivered to RPE for STRA6-mediated uptake by serum
retinol binding protein (SRBP).60 A recent whole-body radiola-
beled tracer study in wild-type mice and mice deficient in
RPE65, an essential retinoid isomerohydrolase, provided evi-
dence that RPE also exhibits a robust efflux of retinoids,29
without specifying the mechanism by which it occurs. Of
apoB-producing organs, only intestine incorporates locally es-
terified retinol into a lipoprotein, and CM remnants deliver
significant retinoid levels to nonhepatic tissues. The liver, in
contrast, releases retinol stored in stellate cells to SRBP.61
Because the RPE expresses lecithin retinol acyl transferase,
which catalyzes retinol esterification,62 it is a plausible source
of BrM-LLP RE. It would be remarkable if nature borrowed a
CM-like mechanism as a vehicle for retinoid removal in the eye.
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